{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:12:55Z","timestamp":1788441175676,"version":"build-2803163510"},"reference-count":46,"publisher":"American Chemical Society (ACS)","issue":"5","license":[{"start":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T00:00:00Z","timestamp":1554854400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK082971"],"award-info":[{"award-number":["DK082971"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["MD009124"],"award-info":[{"award-number":["MD009124"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006691","name":"Harvard Medical School","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100006691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/na","name":"Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sickle cell disease is an inherited disorder of hemoglobin (Hb). During a sickle cell crisis, deoxygenated sickle hemoglobin (deoxyHbS) polymerizes to form fibers in red blood cells (RBCs), causing the cells to adopt \u201csickled\u201d shapes. Using small molecules to increase the affinity of Hb for oxygen is a potential approach to treating sickle cell disease, because oxygenated Hb interferes with the polymerization of deoxyHbS. We have identified a triazole disulfide compound (4,4\u2032-di(1,2,3-triazolyl)disulfide, designated TD-3), which increases the affinity of Hb for oxygen. The crystal structures of carboxy- and deoxy-forms of human adult Hb (HbA), each complexed with TD-3, revealed that one molecule of the monomeric thiol form of TD-3 (5-mercapto-1H-1,2,3-triazole, designated MT-3) forms a disulfide bond with \u03b2-Cys93, which inhibits the salt-bridge formation between \u03b2-Asp94 and \u03b2-His146. This inhibition of salt bridge formation stabilizes the R-state and destabilizes the T-state of Hb, resulting in reduced magnitude of the Bohr effect and increased affinity of Hb for oxygen. Intravenous administration of TD-3 (100 mg\/kg) to C57BL\/6 mice increased the affinity of murine Hb for oxygen, and the mice did not appear to be adversely affected by the drug. TD-3 reduced in vitro hypoxia-induced sickling of human sickle RBCs. The percentage of sickled RBCs and the P50 of human SS RBCs by TD-3 were inversely correlated with the fraction of Hb modified by TD-3. Our study shows that TD-3, and possibly other triazole disulfide compounds that bind to Hb \u03b2-Cys93, may provide new treatment options for patients with sickle cell disease.<\/jats:p>","DOI":"10.1021\/acs.molpharmaceut.8b00108","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T17:10:32Z","timestamp":1523380232000},"page":"1954-1963","source":"Crossref","is-referenced-by-count":23,"title":["A Triazole Disulfide Compound Increases the Affinity\nof Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle\nCells"],"prefix":"10.1021","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7047-1735","authenticated-orcid":true,"given":"Akito","family":"Nakagawa","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School , , , ,","place":["Boston, Massachusetts, United States, 02114"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School , , , ,","place":["Boston, Massachusetts, United States, 02114"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorij","family":"Schleifer","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School , , , ,","place":["Boston, Massachusetts, United States, 02114"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa K.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School , , , ,","place":["Boston, Massachusetts, United States, 02114"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School , , , ,","place":["Boston, Massachusetts, United States, 02114"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binglan","family":"Yu","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School , , , ,","place":["Boston, Massachusetts, United States, 02114"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Berra","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School , , , ,","place":["Boston, Massachusetts, United States, 02114"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Klings","sequence":"additional","affiliation":[{"name":"Boston University School of Medicine , , , ,","place":["Boston, Massachusetts, United States, 02118"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronni S.","family":"Safo","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University , , , ,","place":["Richmond, Virginia, United States, 23298"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiukan","family":"Chen","sequence":"additional","affiliation":[{"name":"The Children\u2019s Hospital of Philadelphia , , , ,","place":["Philadelphia, Pennsylvania, United States, 19104"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faik N.","family":"Musayev","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University , , , ,","place":["Richmond, Virginia, United States, 23298"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-1743","authenticated-orcid":true,"given":"Martin K.","family":"Safo","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University , , , ,","place":["Richmond, Virginia, United States, 23298"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osheiza","family":"Abdulmalik","sequence":"additional","affiliation":[{"name":"The Children\u2019s Hospital of Philadelphia , , , ,","place":["Philadelphia, Pennsylvania, United States, 19104"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald B.","family":"Bloch","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School , , , ,","place":["Boston, Massachusetts, United States, 02114"]},{"name":"Massachusetts General Hospital and Harvard Medical School , , , ,","place":["Boston, Massachusetts, United States, 02114"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren M.","family":"Zapol","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School , , , ,","place":["Boston, Massachusetts, United States, 02114"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"key":"2026090308173393300_cit1","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"key":"2026090308173393300_cit2","unstructured":"Center\nfor Disease Control and Prevention. https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/data.html (accessed on Jan 17, 2018)."},{"issue":"11","key":"2026090308173393300_cit3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1056\/NEJM199709113371107","article-title":"Pathogenesis\nand treatment of sickle cell disease","volume":"337","author":"Bunn","year":"1997","journal-title":"N. Engl.\nJ. Med."},{"key":"2026090308173393300_cit4","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1182\/blood-2017-02-765891","article-title":"Treating sickle cell disease by targeting\nHbS polymerization","volume":"129","author":"Eaton","year":"2017","journal-title":"Blood"},{"key":"2026090308173393300_cit5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"Investigators\nof the Multicenter\nStudy of Hydroxyurea in Sickle Cell, A.; Follow-Up, M. S. H. P., The\nrisks and benefits of long-term use of hydroxyurea in sickle cell\nanemia: A 17.5 year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"Am. J. Hematol."},{"key":"2026090308173393300_cit6","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of\nhydroxyurea on mortality\nand morbidity in adult sickle cell anemia: risks and benefits up to\n9 years of treatment","volume":"289","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"2026090308173393300_cit7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0065-3233(08)60287-9","article-title":"Sickle cell\nhemoglobin polymerization","volume":"40","author":"Eaton","year":"1990","journal-title":"Adv. Protein Chem."},{"key":"2026090308173393300_cit8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1182\/blood-2011-03-325258","article-title":"Fetal hemoglobin\nin sickle cell anemia","volume":"118","author":"Akinsheye","year":"2011","journal-title":"Blood"},{"key":"2026090308173393300_cit9","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood.V89.3.1078","article-title":"Fetal hemoglobin\nin sickle cell anemia: determinants\nof response to hydroxyurea. Multicenter Study of Hydroxyurea","volume":"89","author":"Steinberg","year":"1997","journal-title":"Blood"},{"key":"2026090308173393300_cit10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood.V69.1.109.109","article-title":"Hydroxyurea-induced\naugmentation of fetal hemoglobin production in patients with sickle\ncell anemia","volume":"69","author":"Charache","year":"1987","journal-title":"Blood"},{"key":"2026090308173393300_cit11","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJMct0708272","article-title":"Hydroxyurea\nfor the treatment of sickle cell anemia","volume":"358","author":"Platt","year":"2008","journal-title":"N.\nEngl. J. Med."},{"key":"2026090308173393300_cit12","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1182\/blood-2014-08-435768","article-title":"Update on\nthe use of hydroxyurea therapy in sickle cell disease","volume":"124","author":"Wong","year":"2014","journal-title":"Blood"},{"key":"2026090308173393300_cit13","unstructured":"FDA approved l-glutamine powder for the treatment of sickle\ncell disease. https:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm566097.htm (accessed on Jan 17, 2018)."},{"key":"2026090308173393300_cit14","unstructured":"FDA D.I.S.C.O.: l-glutamine for sickle cell disease. https:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ApprovedDrugs\/ucm572213.htm (accessed on Jan 17, 2018)."},{"key":"2026090308173393300_cit15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0022-2143(97)90062-7","article-title":"Increased red cell\nglutamine availability in sickle cell anemia: demonstration of increased\nactive transport, affinity, and increased glutamate level in intact\nred cells","volume":"130","author":"Niihara","year":"1997","journal-title":"J. Lab. Clin. Med."},{"key":"2026090308173393300_cit16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/(SICI)1096-8652(199806)58:2&lt;117::AID-AJH5&gt;3.0.CO;2-V","article-title":"Oral L-glutamine\ntherapy for sickle cell anemia: I. Subjective clinical improvement\nand favorable change in red cell NAD redox potential","volume":"58","author":"Niihara","year":"1998","journal-title":"Am. J. Hematol."},{"key":"2026090308173393300_cit17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/oxfordjournals.bmb.a071363","article-title":"Structure\nand mechanism of haemoglobin","volume":"32","author":"Perutz","year":"1976","journal-title":"Br. Med. Bull."},{"key":"2026090308173393300_cit18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.biophys.27.1.1","article-title":"The stereochemical\nmechanism of the cooperative effects in hemoglobin revisited","volume":"27","author":"Perutz","year":"1998","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"2026090308173393300_cit19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bjh.14264","article-title":"New developments\nin anti-sickling agents: can drugs directly prevent the polymerization\nof sickle haemoglobin in vivo?","volume":"175","author":"Oder","year":"2016","journal-title":"Br. J. Haematol."},{"key":"2026090308173393300_cit20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.hoc.2013.11.001","article-title":"Therapeutic strategies\nto alter the oxygen affinity\nof sickle hemoglobin","volume":"28","author":"Safo","year":"2014","journal-title":"Hematol. Oncol. Clin.\nNorth Am."},{"key":"2026090308173393300_cit21","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1021\/cb500230b","article-title":"Identification of a Small Molecule that Increases Hemoglobin\nOxygen Affinity and Reduces SS Erythrocyte Sickling","volume":"9","author":"Nakagawa","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"2026090308173393300_cit22","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1172\/JCI24650","article-title":"Enzymatic function of hemoglobin\nas a nitrite reductase that produces NO under allosteric control","volume":"115","author":"Huang","year":"2005","journal-title":"J. Clin. Invest."},{"key":"2026090308173393300_cit23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nm1771","article-title":"SNO-hemoglobin is\nnot essential for red blood cell-dependent hypoxic vasodilation","volume":"14","author":"Isbell","year":"2008","journal-title":"Nat. Med."},{"key":"2026090308173393300_cit24","first-page":"566","article-title":"Acute intravenous toxicity of dimethyl\nsulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol,\nand benzyl alcohol in inbred mouse strains","volume":"44","author":"Montaguti","year":"1994","journal-title":"Arzneimittelforschung"},{"key":"2026090308173393300_cit25","doi-asserted-by":"publisher","first-page":"001","DOI":"10.1385\/1-59259-373-9:001","article-title":"X-ray crystallography of hemoglobins","volume":"82","author":"Safo","year":"2003","journal-title":"Methods Mol. Med."},{"key":"2026090308173393300_cit26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview\nof the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"2026090308173393300_cit27","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1107\/S0907444902015809","article-title":"Structure\nof human carbonmonoxyhemoglobin at 2.16 \u00c5: a snapshot of the\nallosteric transition","volume":"58","author":"Safo","year":"2002","journal-title":"Acta Crystallogr., Sect.\nD: Biol. Crystallogr."},{"key":"2026090308173393300_cit28","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jmb.2006.05.036","article-title":"1.25 \u00c5\nresolution crystal structures of human haemoglobin in the oxy, deoxy\nand carbonmonoxy forms","volume":"360","author":"Park","year":"2006","journal-title":"J. Mol. Biol."},{"key":"2026090308173393300_cit29","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX:\nbuilding new software for\nautomated crystallographic structure determination","volume":"58","author":"Adams","year":"2002","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"key":"2026090308173393300_cit30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development\nof Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"issue":"4","key":"2026090308173393300_cit31","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1365-2141.2004.05332.x","article-title":"5-hydroxymethyl-2-furfural\nmodifies intracellular sickle haemoglobin and inhibits sickling of\nred blood cells","volume":"128","author":"Abdulmalik","year":"2005","journal-title":"Br. J. Haematol."},{"key":"2026090308173393300_cit32","first-page":"60","article-title":"Morphology of sickle cells produced\nin solutions of varying osmolarities","volume":"117","author":"Hijiya","year":"1991","journal-title":"J. Clin.\nLab. Med."},{"key":"2026090308173393300_cit33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0021-9258(18)64376-5","article-title":"Chemistry of Bohr Effect\n1. Reaction of N-ethyl Maleimide\nwith Oxygen-Linked Acid Groups of Hemoglobin","volume":"236","author":"Benesch","year":"1961","journal-title":"J. Biol. Chem."},{"key":"2026090308173393300_cit34","doi-asserted-by":"crossref","first-page":"PC77","DOI":"10.1016\/S0021-9258(19)76433-3","article-title":"The amino acid sequence\naround the \u201creactive sulfhydryl\u201d group of the beta chain\nfrom human hemoglobin","volume":"236","author":"Goldstein","year":"1961","journal-title":"J. Biol. Chem."},{"key":"2026090308173393300_cit35","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0021-9258(18)64110-9","article-title":"The binding\nof N-ethylmaleimide by human hemoglobin and its effect upon the oxygen\nequilibrium","volume":"236","author":"Riggs","year":"1961","journal-title":"J. Biol. Chem."},{"key":"2026090308173393300_cit36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0021-9258(18)87202-7","article-title":"The equilibrium\nbetween oxygen and carbonic acid in blood","volume":"41","author":"Henderson","year":"1920","journal-title":"J.\nBiol. Chem."},{"key":"2026090308173393300_cit37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1101\/SQB.1972.036.01.040","article-title":"Stereochemistry\nof cooperative effects in hemoglobin","volume":"36","author":"Perutz","year":"1972","journal-title":"Cold Spring\nHarbor Symp. Quant. Biol."},{"key":"2026090308173393300_cit38","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1085\/jgp.43.4.737","article-title":"The Nature\nand Significance of the Bohr Effect in Mammalian Hemoglobins","volume":"43","author":"Riggs","year":"1960","journal-title":"J. Gen. Physiol."},{"key":"2026090308173393300_cit39","doi-asserted-by":"publisher","first-page":"11901","DOI":"10.1021\/bi0202880","article-title":"Ligand binding properties\nand structural studies of recombinant and chemically modified hemoglobins\naltered at \u03b293 cysteine","volume":"41","author":"Cheng","year":"2002","journal-title":"Biochemistry"},{"key":"2026090308173393300_cit40","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1021\/bi00555a013","article-title":"Role of\nC-terminal histidine in the\nalkaline Bohr effect of human hemoglobin","volume":"19","author":"Kilmartin","year":"1980","journal-title":"Biochemistry"},{"key":"2026090308173393300_cit41","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0022-2836(80)80022-2","article-title":"Identification\nof residues contributing to the Bohr\neffect of human haemoglobin","volume":"138","author":"Perutz","year":"1980","journal-title":"J. Mol. Biol."},{"key":"2026090308173393300_cit42","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1021\/bi00546a033","article-title":"Role of the\n\u03b2146 histidyl residue\nin the alkaline Bohr effect of hemoglobin","volume":"19","author":"Russu","year":"1980","journal-title":"Biochemistry"},{"key":"2026090308173393300_cit43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0167-4838(90)90056-L","article-title":"Changes of polymerization and conformation\nof hemoglobin S induced by thiol reagents","volume":"1041","author":"Garel","year":"1990","journal-title":"Biochim.\nBiophys. Acta, Protein Struct. Mol. Enzymol."},{"key":"2026090308173393300_cit44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1432-1033.1982.tb05789.x","article-title":"The effect\nof pH and D-glycerate 2,3-bisphosphate on the O2 equilibrium\nof normal and SH(\u03b293)-modified human hemoglobin","volume":"121","author":"Antonini","year":"1982","journal-title":"Eur. J. Biochem."},{"key":"2026090308173393300_cit45","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1432-1033.1982.tb06561.x","article-title":"Binding of 21 Thiol Reagents to Human-Hemoglobin\nin Solution and Intact-Cells","volume":"123","author":"Garel","year":"1982","journal-title":"Eur. J. Biochem."},{"key":"2026090308173393300_cit46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/0005-2795(73)90147-5","article-title":"Sequence\nof amino acids in the chain of single hemoglobins from C57BL, SWR,\nand NB mice","volume":"303","author":"Popp","year":"1973","journal-title":"Biochim. Biophys. Acta, Protein\nStruct."}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.8b00108","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/15\/5\/1954\/67235544\/acs.molpharmaceut.8b00108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article-pdf\/15\/5\/1954\/67235544\/acs.molpharmaceut.8b00108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:17:39Z","timestamp":1788437859000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/mpohbp\/article\/15\/5\/1954\/680098\/A-Triazole-Disulfide-Compound-Increases-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,4,10]]},"published-print":{"date-parts":[[2018,5,7]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00108","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,10]]}}}